Epidemiology and Genetics of Sudden Cardiac Death
Key result
Sudden cardiac death drives over 50% of coronary heart disease deaths, underscoring primary prevention needs.
Population
General population at risk for sudden cardiac death
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
High ongoing SCD burden signals need for enhanced primary prevention; leaves open optimal integration of genetic risk stratification.
Key Points
- To review the population incidence, clinical risk factors, and underlying pathophysiological mechanisms of sudden cardiac death across demographic groups.
- Synthesized findings from population surveillance systems and prospective cohort studies across the United States, Netherlands, Ireland, and China.
- Analyzed autopsy series, emergency medical service registries, and prospective cohort studies tracking cardiac arrest presentation, initial rhythms, and clinical outcomes.
- Annual sudden cardiac death (SCD) incidence in the United States ranges from 180,000 to 450,000 cases, with population rates between 50 and 100 per 100,000 across multiple countries.
- SCD accounts for >50% of all coronary heart disease (CHD) deaths and 15% to 20% of all deaths, yet survival to hospital discharge for emergency medical services-treated out-of-hospital cardiac arrest is only 7.9%.
- CHD represents the underlying substrate in approximately 75% of SCD cases, with pre-existing CHD increasing SCD risk 2.8- to 5.3-fold and congestive heart failure increasing risk 2.6- to 6.2-fold.
Structured PICO
P
Population
A comprehensive review of the epidemiology, risk factors, and genetics of sudden cardiac death in the general population.
This review highlights the significant public health burden of sudden cardiac death and the need for improved risk stratification incorporating clinical, environmental, and genetic factors.
Cite This Study
Deo et al. (2012) conducted a review in Sudden Cardiac Death. Risk factors and genetics of sudden cardiac death was evaluated. Sudden cardiac death accounts for over 50% of all coronary heart disease deaths and 15% to 20% of all deaths, highlighting the need for improved primary prevention and genetic risk stratification.